Profiel
Dr Colas studied molecular biology at the University of Lyon and At the end of 1993, he joined the laboratory of Roger Brent, at the Department of Molecular Biology of Massachusetts General Hospital (Harvard Medical School, Boston, USA), where he contributed to the development of the peptide aptamer technology.
Dr Colas was recruited by the INSERM and came back to Lyon in 1998 to join Dr Rudkin's lab.
He pursued his work on peptide aptamer technologies.
In 2002, Dr Colas took a leave from the INSERM to become Scientific Director of Aptanomics.
Eerdere bekende functies van Pierre Colas
| Bedrijven | Functie | Einde |
|---|---|---|
Aptanomics SA
Aptanomics SA Pharmaceuticals: MajorHealth Technology Develops and manufactures novel therapeutics | Hoofd Techniek/Wetenschap/O&O | 24-01-2008 |
Opleiding van Pierre Colas
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Aptanomics SA
Aptanomics SA Pharmaceuticals: MajorHealth Technology Develops and manufactures novel therapeutics | Health Technology |
Ecole Centrale Lyon
Ecole Centrale Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
École Normale Supérieure de Lyon
École Normale Supérieure de Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















